Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308999385> ?p ?o ?g. }
- W4308999385 endingPage "45" @default.
- W4308999385 startingPage "30" @default.
- W4308999385 abstract "The pathogenesis of connective tissue diseases (CTDs), represented by systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), systemic sclerosis (SSc), primary Sjögren's syndrome (pSS), and idiopathic inflammatory myopathies (IIM), includes various immune cells involved in both innate and adaptive immunity. The mesenchymal stem cells (MSCs) are unique due to their regulatory effect on immunity. This makes them a promising therapeutic approach for patients with immune-mediated disorders such as CTD. The safety and clinical efficacy of MSC treatment in CTD have been tested in a growing number of preclinical and clinical studies. Administration of MSCs has consistently shown benefits with both symptomatic and histologic improvement in CTD animal models. MSC therapies in severe and drug-resistant CTD patients have shown promise in a number of the pilot studies, cohort studies, and randomized controlled trials in SLE, RA, and SSc, but some problems still need to be resolved in the transition from the bench to the bedside. The relevant studies in pSS and IIM are still in their infancy, but have displayed encouraging outcomes. Considerable efficacy variations have been observed in terms of the route of delivery, time of MSC injection, origin of the MSCs and dosage. Furthermore, the optimization of conventional drugs combined with MSC therapies and the applications of novel cell engineering approaches requires additional research. In this review, we summarize the current evidence about the immunoregulatory mechanism of MSCs, as well as the preclinical and clinical studies of MSC-based therapy for the treatment of CTDs." @default.
- W4308999385 created "2022-11-20" @default.
- W4308999385 creator A5001540288 @default.
- W4308999385 creator A5005317435 @default.
- W4308999385 creator A5033838347 @default.
- W4308999385 creator A5042081356 @default.
- W4308999385 creator A5059300419 @default.
- W4308999385 date "2022-11-15" @default.
- W4308999385 modified "2023-10-01" @default.
- W4308999385 title "Mesenchymal stem cells and connective tissue diseases: From bench to bedside" @default.
- W4308999385 cites W1520986136 @default.
- W4308999385 cites W1523128476 @default.
- W4308999385 cites W1565589481 @default.
- W4308999385 cites W1579851397 @default.
- W4308999385 cites W1586233025 @default.
- W4308999385 cites W1602246135 @default.
- W4308999385 cites W1836448277 @default.
- W4308999385 cites W1854383303 @default.
- W4308999385 cites W1917515270 @default.
- W4308999385 cites W1968159361 @default.
- W4308999385 cites W1975190267 @default.
- W4308999385 cites W1976371737 @default.
- W4308999385 cites W1981787940 @default.
- W4308999385 cites W1989632074 @default.
- W4308999385 cites W1996940761 @default.
- W4308999385 cites W2004510831 @default.
- W4308999385 cites W2006601515 @default.
- W4308999385 cites W2011137808 @default.
- W4308999385 cites W2028702444 @default.
- W4308999385 cites W2032187209 @default.
- W4308999385 cites W2035369903 @default.
- W4308999385 cites W2035706135 @default.
- W4308999385 cites W2045472712 @default.
- W4308999385 cites W2046079188 @default.
- W4308999385 cites W2048144970 @default.
- W4308999385 cites W2062160040 @default.
- W4308999385 cites W2063764243 @default.
- W4308999385 cites W2074411680 @default.
- W4308999385 cites W2080003782 @default.
- W4308999385 cites W2081867547 @default.
- W4308999385 cites W2083154922 @default.
- W4308999385 cites W2084615847 @default.
- W4308999385 cites W2089592611 @default.
- W4308999385 cites W2097087492 @default.
- W4308999385 cites W2097792324 @default.
- W4308999385 cites W2111317825 @default.
- W4308999385 cites W2111727066 @default.
- W4308999385 cites W2111864408 @default.
- W4308999385 cites W2114612367 @default.
- W4308999385 cites W2122659446 @default.
- W4308999385 cites W2128154077 @default.
- W4308999385 cites W2131566159 @default.
- W4308999385 cites W2141112460 @default.
- W4308999385 cites W2141532655 @default.
- W4308999385 cites W2144839810 @default.
- W4308999385 cites W2148064846 @default.
- W4308999385 cites W2153953282 @default.
- W4308999385 cites W2166648101 @default.
- W4308999385 cites W2166891424 @default.
- W4308999385 cites W2171439559 @default.
- W4308999385 cites W2235327699 @default.
- W4308999385 cites W2276986098 @default.
- W4308999385 cites W2315168003 @default.
- W4308999385 cites W2328159426 @default.
- W4308999385 cites W2336145754 @default.
- W4308999385 cites W2411914725 @default.
- W4308999385 cites W2415420071 @default.
- W4308999385 cites W2416051724 @default.
- W4308999385 cites W2553749118 @default.
- W4308999385 cites W2558608698 @default.
- W4308999385 cites W2559789899 @default.
- W4308999385 cites W2559996304 @default.
- W4308999385 cites W2566812175 @default.
- W4308999385 cites W2581454228 @default.
- W4308999385 cites W2587847614 @default.
- W4308999385 cites W2593635167 @default.
- W4308999385 cites W2611543513 @default.
- W4308999385 cites W2617752316 @default.
- W4308999385 cites W2626734317 @default.
- W4308999385 cites W2735886478 @default.
- W4308999385 cites W2737405538 @default.
- W4308999385 cites W2742042302 @default.
- W4308999385 cites W2781712675 @default.
- W4308999385 cites W2788028081 @default.
- W4308999385 cites W2791908943 @default.
- W4308999385 cites W2792733823 @default.
- W4308999385 cites W2793599572 @default.
- W4308999385 cites W2793887429 @default.
- W4308999385 cites W2807700854 @default.
- W4308999385 cites W2808205734 @default.
- W4308999385 cites W2809170199 @default.
- W4308999385 cites W2884497909 @default.
- W4308999385 cites W2885402211 @default.
- W4308999385 cites W2886443304 @default.
- W4308999385 cites W2895694114 @default.
- W4308999385 cites W2898054633 @default.
- W4308999385 cites W2900098755 @default.
- W4308999385 cites W2901309469 @default.